Steven L. Hoerter
2015 - Clovis Oncology
In 2015, Steven L. Hoerter earned a total compensation of $2.2M as EVP and Chief Commercial Officer at Clovis Oncology, a 38% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,782,102 |
|---|---|
| Salary | $356,667 |
| Other | $14,254 |
| Total | $2,153,023 |
Hoerter received $1.8M in option awards, accounting for 83% of the total pay in 2015.
Hoerter also received $356.7K in salary and $14.3K in other compensation.
Rankings
In 2015, Steven L. Hoerter's compensation ranked 4,430th out of 13,638 executives tracked by ExecPay. In other words, Hoerter earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,430 out of 13,638 | 68th |
Division Manufacturing | 1,615 out of 5,190 | 69th |
Major group Chemicals And Allied Products | 584 out of 1,854 | 69th |
Industry group Drugs | 463 out of 1,528 | 70th |
Industry Pharmaceutical Preparations | 366 out of 1,182 | 69th |
Source: SEC filing on April 27, 2016.
Hoerter's colleagues
We found five more compensation records of executives who worked with Steven L. Hoerter at Clovis Oncology in 2015.
2015
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2015
Andrew Allen
Clovis Oncology
Chief Medical Officer
2015
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
2015
Gillian Ivers-Read
Clovis Oncology
EVP of Technical Operations and Chief Regulatory Officer
2015
Erle Mast
Clovis Oncology